Now showing items 1-1 of 1

    • Broad HIV-1 inhibition in vitro by vaccine-elicited cd8(+) t cells in African adults. 

      Mutua, G; Farah, B; Langat, R; Indangasi, J; Ogola, S; Onsembe, B; Kopycinski, JT; Hayes, P; Borthwick, NJ; Ashraf, A; Dally, L; Barin, B; Tillander, A; Gilmour, J; De Bont, J; Crook, A; Cox, JH; Anzala, O; Fast, PE; Reilly, M; Chinyenze, K; Jaoko, W; Hanke, T (University of Nairobi, 2016)
      We are developing a pan-clade HIV-1 T-cell vaccine HIVconsv, which could complement Env vaccines for prophylaxis and be a key to HIV cure. Our strategy focuses vaccine-elicited effector T-cells on functionally and structurally ...